ToxicologistA waiver ofIRBJurisdictionDoctor toDoctorLettersAScientificReviewerFourA Noticeof FDAInspectionCaliforniaUn-anticipatedProblem3 yearsafterCompletionof researchA Non-ScientificMemberInstitutionalReviewBoardItemsreviewed byExpeditedReviewDataSafetyMonitoringBoard5MembersCenter forBiologicsEvaluationandResearchFDAa.AdministrativelyClosed byIntegReviewOHRPAt leastAnnuallyMassachusettsPharmaceuticalCompanyHerbalSupplementsDepartmentof HumanHealthServicesInvestigationalNew DrugToxicologistA waiver ofIRBJurisdictionDoctor toDoctorLettersAScientificReviewerFourA Noticeof FDAInspectionCaliforniaUn-anticipatedProblem3 yearsafterCompletionof researchA Non-ScientificMemberInstitutionalReviewBoardItemsreviewed byExpeditedReviewDataSafetyMonitoringBoard5MembersCenter forBiologicsEvaluationandResearchFDAa.AdministrativelyClosed byIntegReviewOHRPAt leastAnnuallyMassachusettsPharmaceuticalCompanyHerbalSupplementsDepartmentof HumanHealthServicesInvestigationalNew Drug

IR-BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Toxicologist
  2. A waiver of IRB Jurisdiction
  3. Doctor to Doctor Letters
  4. A Scientific Reviewer
  5. Four
  6. A Notice of FDA Inspection
  7. California
  8. Un-anticipated Problem
  9. 3 years after Completion of research
  10. A Non-Scientific Member
  11. Institutional Review Board
  12. Items reviewed by Expedited Review
  13. Data Safety Monitoring Board
  14. 5 Members
  15. Center for Biologics Evaluation and Research
  16. FDA
  17. a. Administratively Closed by IntegReview
  18. OHRP
  19. At least Annually
  20. Massachusetts
  21. Pharmaceutical Company
  22. Herbal Supplements
  23. Department of Human Health Services
  24. Investigational New Drug